Skip to main content

Table 3 ErgMS measurements and schedule

From: Ergothioneine supplementation in people with metabolic syndrome (ErgMS): protocol for a randomised, double-blind, placebo-controlled pilot study

Measurement

Study visit

Baseline

6 wks

12 wks

Primary

 Recruitment

   

 Completion

   

 Supplementation compliance

   

Secondary

 Platelet function

   

 MDA

   

 ALT

   

 TNF-α

   

 Nrf2

   

 CRP

   

 Fasting glucose

   

 TAG

   

 HDL-C

   

 Weight

   

 BMI

   

 WC

   

 Systolic BP

   

 Diastolic BP

   
  1. ALT Alanine transaminase, BMI Body mass index, BP Blood pressure, CRP C-reactive protein, HDL-C High-density lipoprotein-cholesterol, MDA Malondialdehyde, Nrf2 Nuclear factor erythroid 2-related factor 2, TAG Triacylglyceride, TNF-α Tumour necrosis factor-alpha, WC Waist circumference, wks Weeks
Back to article page

Pilot and Feasibility Studies

ISSN: 2055-5784